The Chemours Company (CC)
$
13.49
-0.33 (-2.45%)
Key metrics
Financial statements
Free cash flow per share
-5.3162
Market cap
2 Billion
Price to sales ratio
0.3481
Debt to equity
7.5665
Current ratio
1.7531
Income quality
-15.1667
Average inventory
1.5 Billion
ROE
0.0484
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
The Chemours Company, founded in 2014 and headquartered in Wilmington, Delaware, provides performance chemicals across several global regions, including North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through four segments: Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment specializes in TiO2 pigment under the Ti-Pure and BaiMax brands, which deliver essential properties such as whiteness, brightness, opacity, and protection across a range of applications, including architectural and industrial coatings, plastic packaging, and laminate papers. The Thermal & Specialized Solutions segment focuses on refrigerants, thermal management solutions, and foam blowing agents, while the Advanced Performance Materials portfolio contains industrial resins, specialty products, and coatings for various sectors, including consumer electronics and semiconductors. The Chemical Solutions segment offers industrial chemicals vital for multiple uses, such as gold production and water treatment. The company recorded an operating income of $457,000,000.00 reflecting its earnings from core operations. The weighted average number of shares outstanding is $149,494,462.00 highlighting the company's shareholder base. The financial data pertains to the fiscal year $2024 with operating expenses amounting to $694,000,000.00 showcasing the various costs incurred in operations. Additionally, the company earned an interest income of $0.00 illustrating its financial investments in diverse areas. In the investment landscape, the company's stock is affordable at $13.49 making it a suitable option for budget-conscious investors. It features a high average trading volume of 4,266,463.00 indicating strong liquidity that can support active trading strategies. With a mid-range market capitalization of $2,019,102,260.00 the company exemplifies steady performance within its sector. It is a key player in the Chemicals - Specialty industry, contributing significantly to the overall market landscape. Furthermore, it belongs to the Basic Materials sector, driving innovation and growth, which presents prospects for future developments that investors may find appealing.
Is The Chemours Company (CC) a good investment?
Investing in The Chemours Company (CC) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as C+, with a Bullish outlook. Always conduct your own research before investing.
What is The Chemours Company (CC)'s stock forecast?
Analysts predict The Chemours Company stock to fluctuate between $9.13 (low) and $25.54 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is The Chemours Company's market capitalization?
As of 2025-07-15, The Chemours Company's market cap is $2,019,102,260, based on 149,674,000 outstanding shares.
How does The Chemours Company compare to competitors like The Sherwin-Williams Company?
Compared to The Sherwin-Williams Company, The Chemours Company has a Lower Market-Cap, indicating a difference in performance.
Does The Chemours Company pay dividends?
The Chemours Company pays dividends. The current dividend yield is 7.50%, with a payout of $0.09 per share.
How can I buy The Chemours Company (CC) stock?
To buy The Chemours Company (CC) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for CC. Place an order (Market, Limit, etc.).
What is the best time to invest in The Chemours Company?
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
How did The Chemours Company perform in the last earnings report?
Revenue: $5,782,000,000 | EPS: $0.58 | Growth: -136.25%.
Where can I find The Chemours Company's investor relations reports?
Visit https://www.chemours.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for The Chemours Company?
You can explore historical data from here
What is the all-time high and low for The Chemours Company stock?
All-time high: $44.95 (2022-06-06) | All-time low: $9.13 (2025-06-02).
What are the key trends affecting The Chemours Company stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
zacks.com
Chemours' second-quarter sales are expected to be at the high end of its guidance as TT disruptions get offset by Opteon demand boosts.
marketwatch.com
The chemicals company previously forecast sales to increase in the low to mid-teens sequentially, with consolidated adjusted earnings before interest, taxes, depreciation and amortization also expected to increase within a range of 40% to 45%.
businesswire.com
WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--The Chemours Company Provides Update on Second Quarter 2025 Outlook.
businesswire.com
WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Appoints Matthew Conti as Chief Human Resources Officer.
businesswire.com
WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Appoints Technology and Data Center Infrastructure Industry Vet Nathan Blom as Vice President of Liquid Cooling Growth Portfolio.
zacks.com
The deal will enable CC to focus on improving data center efficiency by using two-phase direct-to-chip, two-phase immersion cooling and other new methods.
zacks.com
CC partners with Navin Fluorine to facilitate the adoption of two-phase liquid cooling.
zacks.com
CC's first-quarter earnings miss estimates, but revenues beat the same on increased sales from Titanium Technologies and Thermal & Specialized Solutions.
seekingalpha.com
The Chemours Company (NYSE:CC ) Q1 2025 Results Conference Call May 7, 2025 8:00 AM ET Company Participants Brandon Ontjes - VP, Investor Relations Denise Dignam - President & Chief Executive Officer Shane Hostetter - Chief Financial Officer Conference Call Participants John McNulty - BMO John Roberts - Mizuho Pete Osterland - Truist Laurence Alexander - Research Analyst Arun Viswanathan - RBC Capital Markets Josh Spector - UBS Duffy Fischer - Goldman Sachs Mike Leithead - Barclays Operator Good morning. My name is Michelle, and I will be your conference operator today.
seekingalpha.com
Chemours has faced significant challenges, including weak demand, excess supply, and poor earnings, leading to a 50% drop in stock value and a 9% after-hours plunge. Despite weak performance, Chemours is nearing a potential buy point due to its free cash flow generation and strategic dividend cut to safeguard its balance sheet. CC expects sequential sales growth and a 40-45% increase in adjusted EBITDA, but the outlook remains cautious due to economic uncertainties and tariffs.
See all news
